Figure 2: Overview of mAb approvals. | Nature Biotechnology

Figure 2: Overview of mAb approvals.

From: Biopharmaceutical benchmarks 2018

Figure 2

(a) mAbs approved for the first time in the indicated periods, expressed as a percentage of total biopharmaceuticals approved for the first time in the same time period. (b) mAbs global annual sales value expressed as a percentage of total biopharmaceutical global sales for the indicated years. Financial data from La Merie Business Intelligence.

Back to article page